OBJECTIVE: This study utilized a combination of HPV self-sampling, iFTA elute specimen cards, and long distance transport for centralized processing of specimens to determine the feasibility of large-scale screening in remote and transient populations. METHODS: This study was performed in two locations in Peru (Manchay and Iquitos). The "Just For Me" cervico-vaginal brush and iFTA elute cards were used for the collection and transport of specimens. Samples were shipped via FedEx to China and tested for 14 types of high-risk HPV using PCR based MALDI-TOF. HPV positive women were treated with cryotherapy after VIA triage, and followed-up with colposcopy, biopsy, ECC, and repeat HPV testing at 6 months. RESULTS: Six hundred and forty three women registered, and 632 returned a sample over a 10 day period. Within 2 weeks, specimens were shipped, samples tested, and results received by study staff. Sixty-eight women (10.8%) tested positive, and these results were delivered over 4 days. Fifty-nine HPV positive women (87%) returned for evaluation and treatment, and 2 had large lesions not suitable for cryotherapy. At 6 months, 42 women (74%) returned for follow-up, and 3 had CIN 2 (all positive samples from the endocervical canal). Ninety eight percent of participants reported that they would participate in this type of program again. CONCLUSIONS: Utilizing HPV self-sampling, solid media specimen cards for long distance transport, and centralized high throughput processing, we achieved rapid delivery of results, high satisfaction levels, and low loss to follow-up for cervical cancer screening in remote and transient populations.
OBJECTIVE: This study utilized a combination of HPV self-sampling, iFTA elute specimen cards, and long distance transport for centralized processing of specimens to determine the feasibility of large-scale screening in remote and transient populations. METHODS: This study was performed in two locations in Peru (Manchay and Iquitos). The "Just For Me" cervico-vaginal brush and iFTA elute cards were used for the collection and transport of specimens. Samples were shipped via FedEx to China and tested for 14 types of high-risk HPV using PCR based MALDI-TOF. HPV positive women were treated with cryotherapy after VIA triage, and followed-up with colposcopy, biopsy, ECC, and repeat HPV testing at 6 months. RESULTS: Six hundred and forty three women registered, and 632 returned a sample over a 10 day period. Within 2 weeks, specimens were shipped, samples tested, and results received by study staff. Sixty-eight women (10.8%) tested positive, and these results were delivered over 4 days. Fifty-nine HPV positive women (87%) returned for evaluation and treatment, and 2 had large lesions not suitable for cryotherapy. At 6 months, 42 women (74%) returned for follow-up, and 3 had CIN 2 (all positive samples from the endocervical canal). Ninety eight percent of participants reported that they would participate in this type of program again. CONCLUSIONS: Utilizing HPV self-sampling, solid media specimen cards for long distance transport, and centralized high throughput processing, we achieved rapid delivery of results, high satisfaction levels, and low loss to follow-up for cervical cancer screening in remote and transient populations.
Authors: J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz Journal: J Pathol Date: 1999-09 Impact factor: 7.996
Authors: S Tisci; Y H Shen; D Fife; J Huang; J Goycoolea; C P Ma; J Belinson; Rui-De Huang; Y L Qiao Journal: J Low Genit Tract Dis Date: 2003-04 Impact factor: 1.925
Authors: I A Beck; K D Drennan; A J Melvin; K M Mohan; A M Herz; J Alarcón; J Piscoya; C Velázquez; L M Frenkel Journal: J Clin Microbiol Date: 2001-01 Impact factor: 5.948
Authors: Hui Du; Ji Yi; Ruifang Wu; Suzanne E Belinson; Xinfeng Qu; Bin Yang; Chun Wang; Xin Yi; Jerome L Belinson Journal: Am J Clin Pathol Date: 2011-12 Impact factor: 2.493
Authors: Mark E Sherman; Attila T Lorincz; David R Scott; Sholom Wacholder; Philip E Castle; Andrew G Glass; Iwona Mielzynska-Lohnas; Brenda B Rush; Mark Schiffman Journal: J Natl Cancer Inst Date: 2003-01-01 Impact factor: 13.506
Authors: Carolina E Abuelo; Kimberly L Levinson; Jorge Salmeron; Carlos Vallejos Sologuren; Maria Jose Vallejos Fernandez; Jerome L Belinson Journal: J Community Health Date: 2014-06
Authors: Barrett Sewali; Kolawole S Okuyemi; Asli Askhir; Jerome Belinson; Rachel I Vogel; Anne Joseph; Rahel G Ghebre Journal: Cancer Med Date: 2015-02-04 Impact factor: 4.452
Authors: John S Luque; Jonathan N Maupin; Daron G Ferris; Wendy S Guevara Condorhuaman Journal: Patient Prefer Adherence Date: 2016-10-18 Impact factor: 2.711
Authors: Alfredo Aguilar; Joseph A Pinto; Jhajaira Araujo; Williams Fajardo; Leny Bravo; Luis Pinillos; Carlos Vallejos Journal: Mol Clin Oncol Date: 2016-06-10